“Morphologic leukemia-free state after venetoclax-based therapy in acute myeloid leukemia is associated with high relapse despite preserved short-term survival” (2026) Mediterranean Journal of Hematology and Infectious Diseases, 18(1), p. e2026048. doi:10.4084/MJHID.2026.048.